ArticleJournal of Cancer2024

The efficacy of cetuximab plus PD-1 inhibitors as salvage therapy in PD-1 refractory patients with recurrent or metastatic head and neck squamous cell carcinoma.

Rongrong Hui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.